top of page
Pioneering The Next Generation of Cancer Therapies
News & Events
News & Events
NAYA Therapeutics to Present at the
Network for Optimized Astatine-Labeled Radiopharmaceuticals (NOAR) Europe
Annual Meeting
NAYA Announces Partnership with Alpha Nuclide to Support Clinical Development in China for Its GPC3-Targeting Astatine-211 Alpha Therapy for HCC
NAYA to Partner With Atley Solutions To Accelerate The Development of Its Astatine-211 Radiopharmaceuticals
bottom of page